|
|
|
|
 |
|||
|
|||
In vivo demonstration of subcellular localization of anti-transferrin receptor monoclonal antibody-colloidal gold conjugate in brain capillary endothelium
U Bickel, YS Kang, T Yoshikawa and WM Pardridge
Department of Medicine, UCLA School of Medicine 90024.
To study transcytosis at the blood-brain barrier (BBB) in vivo, we used the internal carotid artery perfusion technique in rats. Brain uptake of the OX26 anti-transferrin receptor antibody (IgG2a) coupled to 5-nm colloidal gold (OX26-Au) was morphologically examined after infusion or perfusion into the carotid artery for 10 min. The brain tissue was subsequently perfusion-fixed with 2% glutaraldehyde. By light microscopy, silver enhancement of vibratome sections revealed staining of the vascular tree. Electron microscopy showed binding of gold particles at the luminal plasma membrane of brain capillary endothelia, endocytosis in vesicles (50-100 nm), and particles beyond the abluminal plasma membrane. Studies were performed with an IgG2a isotype control, UPC10. Internal carotid artery infusion of [125I]-UPC10 showed no evidence of brain uptake or binding to endothelium. However, microvessel structures were identified after silver enhancement of vibratome sections of brain following internal carotid artery infusion of 5-nm colloidal gold conjugates of UPC10 (UPC10-Au). The morphologically observed binding of UPC10-Au to brain microvessels may be induced by gold conjugation. These studies describe the use of gold conjugates of antibodies to delineate the subcellular pathway involved in transcytosis through the BBB.
Volume 42,
Issue 11,
pp. 1493-1497,
11/01/1994
Copyright © 1994 by The Histochemical Society
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Panes, M. Aceituno, F. Gil, R. Miquel, J. M Pique, A. Salas, and P. McLean Efficacy of an inhibitor of adhesion molecule expression (GI270384X) in the treatment of experimental colitis Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G739 - G748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang and W. M. Pardridge Delivery of {beta}-Galactosidase to Mouse Brain via the Blood-Brain Barrier Transferrin Receptor J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1075 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Soriano-Izquierdo, M. Gironella, A. Massaguer, F. E. B. May, A. Salas, M. Sans, R. Poulsom, L. Thim, J. M. Pique, and J. Panes Trefoil peptide TFF2 treatment reduces VCAM-1 expression and leukocyte recruitment in experimental intestinal inflammation J. Leukoc. Biol., February 1, 2004; 75(2): 214 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-W. Song, H. V. Vinters, D. Wu, and W. M. Pardridge Enhanced Neuroprotective Effects of Basic Fibroblast Growth Factor in Regional Brain Ischemia after Conjugation to a Blood-Brain Barrier Delivery Vector J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 605 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, W. M. Pardridge, and R. F. Keep Neuroprotection in Transient Focal Brain Ischemia After Delayed Intravenous Administration of Brain-Derived Neurotrophic Factor Conjugated to a Blood-Brain Barrier Drug Targeting System Editorial Comment Stroke, June 1, 2001; 32(6): 1378 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Lee, B. Engelhardt, J. Lesley, U. Bickel, and W. M. Pardridge Targeting Rat Anti-Mouse Transferrin Receptor Monoclonal Antibodies through Blood-Brain Barrier in Mouse J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1048 - 1052. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Kurihara and W. M. Pardridge Imaging Brain Tumors by Targeting Peptide Radiopharmaceuticals through the Blood-Brain Barrier Cancer Res., December 1, 1999; 59(24): 6159 - 6163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. Li, K. Sugimura, R. J.Boado, H. J. Lee, C. Zhang, S. Duebel, and W. M.Pardridge Genetically engineered brain drug delivery vectors: cloning, expression and in vivo application of an anti-transferrin receptor single chain antibody–streptavidin fusion gene and protein Protein Eng. Des. Sel., September 1, 1999; 12(9): 787 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Wu and W. M. Pardridge Neuroprotection with noninvasive neurotrophin delivery to the brain PNAS, January 5, 1999; 96(1): 254 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Carlevaro, A. Albini, D. Ribatti, C. Gentili, R. Benelli, S. Cermelli, R. Cancedda, and F. D. Cancedda Transferrin Promotes Endothelial Cell Migration and Invasion: Implication in Cartilage Neovascularization J. Cell Biol., March 24, 1997; 136(6): 1375 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Huwyler, D. Wu, and W. M. Pardridge Brain drug delivery of small molecules using immunoliposomes PNAS, November 26, 1996; 93(24): 14164 - 14169. [Abstract] [Full Text] [PDF]
|
|
| Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact |